EYLER CHARLES R 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Jan 24, 2019
Insider Transaction Report
Form 4
EYLER CHARLES R
SR. VP-FINANCE & TREASURER
Transactions
- Sale
COMMON STOCK
2019-01-22$24.80/sh−713$17,682→ 32,044 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units.